(Q38151057)

29 August 2017

title

At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias (English)

1 reference

29 August 2017

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24108703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Haakan Norell

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24108703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Alessandro Moretta

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24108703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Lorenzo Moretta

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24108703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

9 October 2013

1 reference

Journal of Leukocyte Biology

29 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24108703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24108703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24108703%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

1123-1139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24108703%20AND%20SRC:MED&resulttype=core&format=json

At the Bedside: Innate immunity as an immunotherapy tool for hematological malignancies

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Transplantation in the onco-hematology field: focus on the manipulation of αβ and γδ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Natural killer cell-based immunotherapy in cancer: current insights and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Adoptive immunotherapy for cancer: harnessing the T cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Therapeutic cancer vaccines: are we there yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Immunotherapy for advanced melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Immunosuppressive strategies that are mediated by tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Interstitial guidance of cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Intratumor heterogeneity: evolution through space and time

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Vγ9Vδ2 T cell-based immunotherapy in hematological malignancies: from bench to bedside.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Receptors for HLA class-I molecules in human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Killer Ig–like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human NK receptors: from the molecules to the therapy of high risk leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human NK cells can control CMV infection in the absence of T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Biology of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Natural killer cells and dendritic cells: rendezvous in abused tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Rituximab infusion induces NK activation in lymphoma patients with the high-affinity CD16 polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

In search of the 'missing self': MHC molecules and NK cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recogn

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificitie

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Coexpression of two functionally independent p58 inhibitory receptors in human natural killer cell clones results in the inability to kill all normal allogeneic target cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Specific lysis of allogeneic cells after activation of CD3- lymphocytes in mixed lymphocyte culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Cytolytic T lymphocytes displaying natural killer (NK)-like activity: expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Identification of HLA-E-specific alloreactive T lymphocytes: a cell subset that undergoes preferential expansion in mixed lymphocyte culture and displays a broad cytolytic activity against allogeneic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

NK-CTLs, a novel HLA-E-restricted T-cell subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

p46, a novel natural killer cell-specific surface molecule that mediates cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Activating interactions in human NK cell recognition: the role of 2B4-CD48

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Differentiation plasticity of hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Shared dependence on the DNA-binding factor TOX for the development of lymphoid tissue–inducer cell and NK cell lineages

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Methylprednisolone induces preferential and rapid differentiation of CD34+ cord blood precursors toward NK cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Natural killer-cell differentiation by myeloid progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human natural killer cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Evidence for discrete stages of human natural killer cell differentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

NK cells can generate from precursors in the adult human liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Innate lymphoid cells: emerging insights in development, lineage relationships, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

[gamma][delta] cells: a right time and a right place for a conserved third way of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human Vgamma9Vdelta2 T cells: from signals to functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Oncogenic stress sensed by the immune system: role of natural killer cell receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to gammadelta T-cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

The NKG2D ligand ULBP4 binds to TCRgamma9/delta2 and induces cytotoxicity to tumor cells through both TCRgammadelta and NKG2D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

PVR (CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112)

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

DNAX Accessory Molecule-1 Mediated Recognition of Freshly Isolated Ovarian Carcinoma by Resting Natural Killer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human Vdelta1 gamma-delta T cells exert potent specific cytotoxicity against primary multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

ATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Antibody-dependent anti-cytomegalovirus activity of human γδ T cells expressing CD16 (FcγRIIIa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

V gamma 9 V delta 2 T cell cytotoxicity against tumor cells is enhanced by monoclonal antibody drugs--rituximab and trastuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Optimizing tumor-reactive γδ T cells for antibody-based cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Gamma delta T cells provide an early source of interferon gamma in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Hematopoietic stem cell transplantation for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Current status of haploidentical stem cell transplantation for leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Evidence of a natural killer (NK) cell repertoire for (allo) antigen recognition: definition of five distinct NK-determined allospecificities in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Preservation of immune repertoire by selective depletion of haploidentical grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

New approaches to graft engineering for haploidentical bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Negative depletion of CD3(+) and TcRαβ(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Expression of the HLA-C2-specific activating killer-cell Ig-like receptor KIR2DS1 on NK and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Gammadelta T cells: functional plasticity and heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Tumor-promoting versus tumor-antagonizing roles of γδ T cells in cancer immunotherapy: results from a prospective phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

New views on natural killer cell-based immunotherapy for melanoma treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Natural and synthetic non-peptide antigens recognized by human gamma delta T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Tumor-infiltrating gammadelta T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Viral subversion of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Cytokine-induced memory-like natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

NK cells and immune "memory"

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Cutting edge: IL-15-independent NK cell response to mouse cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Persistence of natural killer cells with expansion of a hypofunctional CD56-CD16+KIR+NKG2C+ subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Implication of gammadelta T cells in the human immune response to cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Shared reactivity of V{delta}2(neg) {gamma}{delta} T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Human cytomegalovirus elicits fetal gammadelta T cell responses in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Antitumor activity of gammadelta T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Anti-metastatic potential of human Vδ1(+) γδ T cells in an orthotopic mouse xenograft model of colon carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Rapid alphabeta TCR-mediated responses in gammadelta T cells transduced with cancer-specific TCR genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

In vitro comparison of three different chimeric receptor-modified effector T-cell populations for leukemia cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Alpha beta T cell receptor transfer to gamma delta T cells generates functional effector cells without mixed TCR dimers in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312

Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1189%2FJLB.0613312